Stelac Advisory Services’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Stelac Advisory Services’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$122K	Buy	+1,724	New	+$105K	0.02%	150
2025 Q2	–	Sell	-3,751	Closed	-$120K	–	109
2025 Q1	$120K	Buy	3,751 +755	+25%	+$28.7K	0.05%	93
2024 Q4	$116K	Hold	2,996	–	–	0.05%	100
2024 Q3	$135K	Hold	2,996	–	–	0.05%	93
2024 Q2	$125K	Hold	2,996	–	–	0.05%	97
2024 Q1	$136K	Hold	2,996	–	–	0.06%	90
2023 Q4	$139K	Hold	2,996	–	–	0.07%	77
2023 Q3	$122K	Hold	2,996	–	–	0.07%	94
2023 Q2	$145K	Hold	2,996	–	–	0.06%	137
2023 Q1	$148K	Hold	2,996	–	–	0.06%	137
2022 Q4	$152K	Sell	2,996 -190	-6%	-$9.8K	0.07%	133
2022 Q3	$160K	Hold	3,186	–	–	0.07%	135
2022 Q2	$156K	Buy	3,186 +1,326	+71%	+$67.2K	0.06%	143
2022 Q1	$112K	Buy	1,860 +97	+6%	+$6.12K	0.04%	161
2021 Q4	$140K	Buy	+1,763	New	+$148K	0.04%	165

Other funds holding GNOM

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Wealth Management Partners Tucson, Arizona $426M AUM 43.17% 1-Year Est. Return

Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return

Polaris Financial Partners Westerville, Ohio $223M AUM

Creative Financial Designs Kokomo, Indiana $2.22B AUM 15.38% 1-Year Est. Return

Sightline Wealth Advisors Groton, Connecticut $215M AUM 10.46% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

J.W. Cole Advisors Tampa, Florida $5.93B AUM 23.96% 1-Year Est. Return

Armis Advisers Atlanta, Georgia $1.2B AUM 15.74% 1-Year Est. Return

Stelac Advisory Services's GNOM Position: Q3 2026 in Review

Stelac Advisory Services opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q3 2026: 1,724 shares worth $122K. The stake represents 0.02% of the portfolio and ranks #150 among its holdings. This is a return to the name: Stelac Advisory Services previously reported a position in GNOM as recently as Q1 2025.

Stelac Advisory Services first reported a position in GNOM in Q4 2021 and has held it in 15 quarters since. The position peaked at $160K in Q3 2022. 28 funds tracked by Wall St. Rank hold GNOM as of Q3 2026.

Stelac Advisory Services held 1,724 shares of Global X Genomics & Biotechnology ETF worth $122K as of Q3 2026.
Global X Genomics & Biotechnology ETF was a new Stelac Advisory Services position in Q3 2026.
Global X Genomics & Biotechnology ETF made up 0.02% of Stelac Advisory Services's portfolio in Q3 2026, its #150 holding.
Stelac Advisory Services first reported a position in Global X Genomics & Biotechnology ETF in Q4 2021 and has held it in 15 quarters since.
Stelac Advisory Services's Global X Genomics & Biotechnology ETF position peaked at $160K in Q3 2022.
28 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2026.

Based on Stelac Advisory Services's 13F filing for Q3 2026, filed 10 Nov 2026.